Previously processed charges are non-refundable per the published Terms
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
The company saw an impressive 56% year-over-year (YOY) boost to revenue, thanks in large part to $12.8 billion in combined sales of its two main GLP-1 agonists, Mounjaro and Zepbound
however, the neuropsychiatric efficacy of GLP-1/GIP dual agonists remains to be established
They have been practice-changing owing to their glycaemic, cardiovascular, renal and weight loss benefits, and decreases in all-cause mortality
Known as Medical Assistance in the commonwealth, it covers approximately 3 million Pennsylvanians right now at a cost of billions in state dollars each year